Literature DB >> 18410742

Regulation of bone remodeling by the central and peripheral nervous system.

Florent Elefteriou1.   

Abstract

The homeostatic nature of bone remodeling has become a notion further supported lately by the demonstration that neuropeptides and their receptors regulate osteoblast and osteoclast function in vivo. Following initial studies reporting the presence of nerves and nerve-derived products within the bone microenvironment and the expression of receptors for these neuropeptides in bone cells, new experimental and mechanistic evidence based on in vivo murine genetic and pharmacologic models recently demonstrated that inputs from the central and peripheral nervous system feed into the already complex regulatory machinery controlling bone remodeling. The function of a number of "osteo-neuromediators" has been characterized, including norepinephrine and the beta2-adrenergic receptor, Neuropeptide Y and the Y1 and Y2 receptors, endocannabinoids and the CB1 and CB2 receptors, as well as dopamine, serotonin and their receptors and transporters, Calcitonin gene-related peptide, and neuronal NOS. This new body of evidence suggests that neurons in the central nervous system integrate clues from the internal and external milieux, such as energy homeostasis, glycemia or reproductive signals, with the regulation of bone remodeling. The next major tasks in this new area of bone biology will be to understand, at the molecular level, the mechanisms by which common central neural systems regulate and integrate these major physiological functions, the relative importance of the central and peripheral actions of neuropeptides present in both compartments and their relationship, and how bone cells signal back to central centers, because the definition of a homeostatic function implies the existence of feedback signals. Together, these findings shed a new light on the complexity of the mechanisms regulating bone remodeling and uncovered new potential therapeutic strategies for the design of bone anabolic treatments. This review summarizes the latest advances in this area, focusing on investigations based on in vivo animal studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18410742      PMCID: PMC2430105          DOI: 10.1016/j.abb.2008.03.016

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  103 in total

1.  Effects of calcitonin gene-related peptide on bone turnover in ovariectomized rats.

Authors:  K Valentijn; A P Gutow; N Troiano; C Gundberg; J P Gilligan; A Vignery
Journal:  Bone       Date:  1997-09       Impact factor: 4.398

2.  Inhibition of the serotonin (5-hydroxytryptamine) transporter reduces bone accrual during growth.

Authors:  Stuart J Warden; Alexander G Robling; Megan S Sanders; Michael M Bliziotes; Charles H Turner
Journal:  Endocrinology       Date:  2004-11-11       Impact factor: 4.736

3.  Beta-blocker use, bone mineral density, and fracture risk in older women: results from the Epidemiologie de l'Osteoporose prospective study.

Authors:  Régis Levasseur; Patricia Dargent-Molina; Jean-Pierre Sabatier; Christian Marcelli; Gérard Bréart
Journal:  J Am Geriatr Soc       Date:  2005-03       Impact factor: 5.562

4.  Calcitonin gene related peptide enhances bone colony development in vitro.

Authors:  C Shih; G W Bernard
Journal:  Clin Orthop Relat Res       Date:  1997-01       Impact factor: 4.176

5.  Beta-blocker use and risk of fractures in men and women from the general population: the MONICA/KORA Augsburg cohort study.

Authors:  C Meisinger; M Heier; O Lang; A Döring
Journal:  Osteoporos Int       Date:  2007-03-01       Impact factor: 4.507

6.  Neurotransmitter action in osteoblasts: expression of a functional system for serotonin receptor activation and reuptake.

Authors:  M M Bliziotes; A J Eshleman; X W Zhang; K M Wiren
Journal:  Bone       Date:  2001-11       Impact factor: 4.398

7.  An endogenous cannabinoid (2-AG) is neuroprotective after brain injury.

Authors:  D Panikashvili; C Simeonidou; S Ben-Shabat; L Hanus; A Breuer; R Mechoulam; E Shohami
Journal:  Nature       Date:  2001-10-04       Impact factor: 49.962

8.  Effects of calcitonin gene-related peptide on cyclic AMP formation in chicken, rat, and mouse bone cells.

Authors:  V P Michelangeli; A E Fletcher; E H Allan; G C Nicholson; T J Martin
Journal:  J Bone Miner Res       Date:  1989-04       Impact factor: 6.741

9.  Human synthetic calcitonin gene-related peptide inhibits bone resorption in vitro.

Authors:  S M D'Souza; I MacIntyre; S I Girgis; G R Mundy
Journal:  Endocrinology       Date:  1986-07       Impact factor: 4.736

Review 10.  Neuromedin U and its receptors: structure, function, and physiological roles.

Authors:  Paul J Brighton; Philip G Szekeres; Gary B Willars
Journal:  Pharmacol Rev       Date:  2004-06       Impact factor: 25.468

View more
  71 in total

Review 1.  New roles of carboxypeptidase E in endocrine and neural function and cancer.

Authors:  Niamh X Cawley; William C Wetsel; Saravana R K Murthy; Joshua J Park; Karel Pacak; Y Peng Loh
Journal:  Endocr Rev       Date:  2012-03-07       Impact factor: 19.871

Review 2.  Evolving concepts in neurogenic osteoporosis.

Authors:  Weiping Qin; William A Bauman; Christopher P Cardozo
Journal:  Curr Osteoporos Rep       Date:  2010-12       Impact factor: 5.096

3.  Factors that affect postnatal bone growth retardation in the twitcher murine model of Krabbe disease.

Authors:  Miguel Agustin Contreras; William Louis Ries; Srinivasan Shanmugarajan; Gonzalo Arboleda; Inderjit Singh; Avtar Kaur Singh
Journal:  Biochim Biophys Acta       Date:  2010-05-02

Review 4.  A four-season molecule: osteocalcin. Updates in its physiological roles.

Authors:  Giovanni Lombardi; Silvia Perego; Livio Luzi; Giuseppe Banfi
Journal:  Endocrine       Date:  2014-08-27       Impact factor: 3.633

5.  Expression of neuropeptides and bone remodeling-related factors during periodontal tissue regeneration in denervated rats.

Authors:  Xijiao Yu; Linlin Lv; Jing Zhang; Ting Zhang; Changjie Xiao; Shu Li
Journal:  J Mol Histol       Date:  2015-02-07       Impact factor: 2.611

6.  Pth4, an ancient parathyroid hormone lost in eutherian mammals, reveals a new brain-to-bone signaling pathway.

Authors:  Paula Suarez-Bregua; Eva Torres-Nuñez; Ankur Saxena; Pedro Guerreiro; Ingo Braasch; David A Prober; Paloma Moran; Jose Miguel Cerda-Reverter; Shao Jun Du; Fatima Adrio; Deborah M Power; Adelino V M Canario; John H Postlethwait; Marianne E Bronner; Cristian Cañestro; Josep Rotllant
Journal:  FASEB J       Date:  2016-10-24       Impact factor: 5.191

Review 7.  Marrow fat metabolism is linked to the systemic energy metabolism.

Authors:  Beata Lecka-Czernik
Journal:  Bone       Date:  2011-07-04       Impact factor: 4.398

Review 8.  Bone cell communication factors and Semaphorins.

Authors:  Takako Negishi-Koga; Hiroshi Takayanagi
Journal:  Bonekey Rep       Date:  2012-09-19

9.  Pulsed focused ultrasound treatment of muscle mitigates paralysis-induced bone loss in the adjacent bone: a study in a mouse model.

Authors:  Sandra L Poliachik; Tatiana D Khokhlova; Yak-Nam Wang; Julianna C Simon; Michael R Bailey
Journal:  Ultrasound Med Biol       Date:  2014-05-21       Impact factor: 2.998

10.  Inner Ear Vestibular Signals Regulate Bone Remodeling via the Sympathetic Nervous System.

Authors:  Guillaume Vignaux; Jean Dlc Ndong; Daniel S Perrien; Florent Elefteriou
Journal:  J Bone Miner Res       Date:  2015-06       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.